Endocannabinoid regulation of the corticoaccumbens pathway and stress-enhanced cocaine-seeking behavior
内源性大麻素对伏隔皮质通路的调节和压力增强的可卡因寻求行为
基本信息
- 批准号:10750394
- 负责人:
- 金额:$ 4.51万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-08-09 至 2026-08-08
- 项目状态:未结题
- 来源:
- 关键词:AbstinenceAcuteAffectAmericanAreaAttenuatedBehaviorBehavioralBehavioral ModelBrainCNR1 geneCocaineCocaine use disorderComplexCorticosteroneDataDedicationsDiseaseDisinhibitionDrug InteractionsEndocannabinoidsFDA approvedFiberGoalsHealthHumanIn Situ HybridizationIndividualIntakeInterneuronsKnowledgeMeasurementMeasuresMediatingModelingMolecularNeurobiologyNeuronsNeurotransmittersNucleus AccumbensOutcomeOutputPathologicPathway interactionsPatternPersonal SatisfactionPharmaceutical PreparationsPhotometryPopulationPositioning AttributePrefrontal CortexPrevalenceRattusRecording of previous eventsRegulationResearchResearch PersonnelRewardsRodentRoleSelf AdministrationSignal TransductionSiteStimulusStressSubstance Use DisorderSystemTestingTimeaddictionantagonistattenuationbehavior influencecell typecocaine cravingcocaine seekingcocaine self-administrationcocaine usedrug seeking behaviorendocannabinoid signalingendogenous cannabinoid systemexperimental studyhippocampal pyramidal neuronin vivoinnovationinsightneuroadaptationneurophysiologyneuroregulationneurotransmissionpharmacologicpre-clinicalskillsstressor
项目摘要
Project Summary
Cocaine use is a serious and growing concern for public wellbeing, yet there is no FDA-approved treatment
option for individuals with cocaine use disorder (CUD), making it a critical unmet need. CUD is a complex
disorder that is influenced by many external factors, such as stress. Despite the prevalence of stress
throughout human populations, including individuals with CUD, most pre-clinical addiction research does not
examine the impact of stress during drug intake. To understand how stress and drug intake interact to
influence behavioral and neurobiological outcomes, we developed a rat model of cocaine self-administration
(SA) that combines repeated stress at the time of cocaine self-administration in rats. This model causes an
escalation of cocaine intake in otherwise stable responding rats and a long-lasting enhancement of cocaine-
seeking behavior. We propose that this behavioral shift is regulated by changes in the endocannabinoid (eCB)
system, which uniquely regulates stress and reward systems. In support of this, systemic administration of a
cannabinoid receptor 1 (CB1R) antagonist attenuates cocaine-induced reinstatement only in rats with a history
of stress. Furthermore, my preliminary data localizes this effect to the prelimbic cortex (PLc), a key site for
regulation of stress and drug-seeking behavior. Importantly, eCB signaling, through attenuation of local
inhibitory neurotransmission, is well-positioned to regulate PLc pyramidal neuron activity and output. One such
PLc output is to the nucleus accumbens core (NAcc), which has been shown to regulate cocaine-seeking
behavior. Therefore, this proposal tests the hypothesis that stress and cocaine-evoked changes in eCB
signaling during cocaine SA permits enhanced cocaine seeking via disinhibition of the PLc to NAcc circuit.
First, this proposal will use PLc-directed CB1R pharmacological manipulation to assess the role of eCB
signaling in cocaine-primed reinstatement for rats with a history of cocaine SA and/or repeated stress. Next,
we will use in vivo fiber photometry to record activity of the PLc→NAcc circuit during cocaine-primed
reinstatement in rats with a history of stress or no stress. This will allow us to measure the individual or
combined impact of a history of cocaine SA and/or repeated stress on cocaine-seeking behavior. Finally, using
in situ hybridization, we will examine how cocaine SA and/or repeated stress produce long-term changes in the
molecular machinery regulating eCB signaling at the PLc→NAcc circuit. These studies will expand our
knowledge of stress-drug interactions and may yield new treatment options in individuals with CUD for whom
stress is a predominant contributing factor.
项目摘要
可卡因的使用是一个严重的和日益增长的关注公众福祉,但没有FDA批准的治疗
可卡因使用障碍(CUD)患者的选择,使其成为一个关键的未满足的需求。CUD是一种复杂的
受许多外部因素影响的疾病,如压力。尽管压力很大
在整个人群中,包括CUD患者,大多数临床前成瘾研究都没有
研究药物摄入过程中压力的影响。为了了解压力和药物摄入如何相互作用,
影响行为和神经生物学结果,我们开发了一种可卡因自我给药的大鼠模型,
(SA)这结合了大鼠自我给予可卡因时的反复压力。这种模式导致了
在其他方面稳定的反应大鼠中可卡因摄入量的增加和可卡因的持久增强-
寻求行为。我们认为,这种行为转变是由内源性大麻素(eCB)的变化调节的。
系统,它独特地调节压力和奖励系统。为了支持这一点,系统地管理
大麻素受体1(CB 1 R)拮抗剂仅在有病史的大鼠中减弱可卡因诱导的复吸
压力此外,我的初步数据将这种效应定位于前边缘皮层(PLc),这是一个关键部位,
调节压力和寻求药物的行为。重要的是,eCB信号传导,通过减弱局部
抑制性神经传递,很好地定位于调节PLc锥体神经元活性和输出。一个这样
PLc的输出是到丘脑核(NAcc),这已被证明是调节可卡因寻求
行为因此,该提案测试了压力和可卡因诱发的eCB变化的假设,
可卡因SA期间的信号传导允许通过PLc到NAcc回路的去抑制来增强可卡因寻求。
首先,该提案将使用PLC指导的CB 1 R药理学操作来评估eCB的作用
在可卡因引发的恢复与可卡因SA和/或反复应激史的大鼠的信号。接下来,
我们将使用体内纤维光度法记录可卡因引发期间PLc→NAcc回路的活动
在有应激史或无应激史的大鼠中恢复。这将使我们能够衡量个人或
可卡因SA史和/或反复应激对可卡因寻求行为的综合影响。最后利用
在原位杂交,我们将研究如何可卡因SA和/或重复的压力产生长期的变化,
在PLc→NAcc回路中调节eCB信号传导的分子机制。这些研究将扩大我们的
了解压力-药物相互作用,并可能为CUD患者提供新的治疗选择,
压力是主要的影响因素。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Andrew Gaulden其他文献
Andrew Gaulden的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 4.51万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 4.51万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 4.51万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 4.51万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 4.51万 - 项目类别:
Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 4.51万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 4.51万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 4.51万 - 项目类别:
Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 4.51万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 4.51万 - 项目类别:
Operating Grants














{{item.name}}会员




